• Home  
  • Roche, Merck, Silence, AltruBio, Hansoh: Readout Newsletter
Roche, Merck, Silence, AltruBio, Hansoh: Readout Newsletter
- Health

Roche, Merck, Silence, AltruBio, Hansoh: Readout Newsletter

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. I haven’t yet watched the new Elizabeth Holmes documentary, so I haven’t yet read this review by Theranos whistleblower Tyler Schultz (since it contains spoilers). But if you’ve seen the movie, go ahead and read the review (and don’t spoil anything for me).

Roche continues to look to China for new drugs

China’s Hansoh Pharmaceutical Group said yesterday it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.

STAT+ Exclusive Story





This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Source: www.statnews.com

About Us

Reportage Media Is a Global News Platform Covering the Latest Developments and Breaking Stories from Around The World, Including World News, Business, Finance, Technology, Health, Politics, Science, Entertainment, Sports, and More.

Reportage Media

Reportage.Media  @2026. All Rights Reserved.